Picture of Zomedica logo

ZOM Zomedica Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Zomedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.6-19.8-16.9-18.4-17
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items5.733.331.866.847.01
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.4340.03-1.72-1.35-3.35
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-11.1-15.6-16.2-14.3-11.7
Capital Expenditures-0.628-0.687-0.017-0.526-2.79
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.00901.02-71.4-153
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.619-0.6871.01-71.9-156
Financing Cash Flow Items8.222.29-5.11-14.30
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities10.314.976.72190.008
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.51-1.4361.5133-168

Or unlock with your email

Or unlock with your email